Medicine
Doxycycline 100 mg/10 mL powder for injection
Doxycycline 100 mg/10 mL powder for injection is a generic prescription medicine for intravenous use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT.
Key facts
- Active ingredient (INN)
- Doxycycline
- Brand
- Sold under the generic name
- Strength
- 100 mg/10 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials, 1 vial, 5 vials and 18 more
- Manufacturers
- Zydus LifesciencesIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaGland PharmaIndiaLupinIndiaPiramal Critical CareIndiaHealthFirstSlate Run PharmaceuticalsAmneal PharmaceuticalsAvenacy
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AB22 Doxycycline
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 February 2018
- Identifiers
- RxCUI 310027, 1998483DailyMed set ID dd70368b-1949-4833-9d1e-f9f4cdacd9f3, fd672959-014f-8300-e053-6394a90a5ec5, 7ce80f6e-3c0d-4978-b626-5fd3f3ff349e +14NDC 0404-9855, 66794-237, 68382-911 +17Application ANDA091406, ANDA215583, ANDA207757 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 10 mL in 1 vial | 68382-910-10 | Zydus LifesciencesIndia | 1 February 2018 |
| 1 vial in 1 carton / 20 mL in 1 vial | 68382-911-01 | Zydus LifesciencesIndia | 1 February 2018 |
| 10 vial in 1 carton / 10 mL in 1 vial | 70771-1121-6 | Zydus LifesciencesIndia | 1 February 2018 |
| 1 vial in 1 carton / 20 mL in 1 vial | 70771-1122-1 | Zydus LifesciencesIndia | 1 February 2018 |
| 10 vial in 1 carton / 10 mL in 1 vial | 31722-371-32 | Camber PharmaceuticalsIndia | 5 August 2025 |
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 43598-086-58 | Dr. Reddy's LaboratoriesIndia | 18 July 2025 |
| 10 vial in 1 carton / 10 mL in 1 vial | 68083-481-10 | Gland PharmaIndia | 12 April 2023 |
| 10 vial in 1 carton / 10 mL in 1 vial | 70748-338-10 | LupinIndia | 31 May 2024 |
| 10 vial in 1 carton / 10 mL in 1 vial | 66794-237-41 | Piramal Critical CareIndia | 5 June 2023 |
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 70436-032-82 | Slate Run Pharmaceuticals | 22 July 2024 |
| 10 vial, single-dose in 1 carton / 20 mL in 1 vial, single-dose | 70436-201-82 | Slate Run Pharmaceuticals | 22 July 2024 |
| 10 vial in 1 carton / 10 mL in 1 vial | 70121-1616-7 | Amneal Pharmaceuticals | 6 December 2024 |
| 5 vial in 1 carton / 10 mL in 1 vial | 72266-237-05 | Fosun Pharma | 12 April 2023 |
| 10 vial in 1 carton / 10 mL in 1 vial | 86211-116-10 | Jvet Pharmaceuticals | 27 January 2026 |
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 71288-030-21 | Meitheal Pharmaceuticals | 28 October 2024 |
| 10 vial in 1 carton / 10 mL in 1 vial | 67457-437-10 | Mylan Institutional | 20 December 2018 |
| 10 vial in 1 carton / 10 mL in 1 vial | 42023-244-10 | Par Health | 26 November 2024 |
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 83634-111-20 | Avenacy | 1 March 2025 |
| 10 mL in 1 vial | 51662-1402-1 | HealthFirst | 7 October 2019 |
| 10 pouch in 1 box / 1 vial in 1 pouch / 10 mL in 1 vial | 51662-1402-3 | HealthFirst | 16 March 2022 |
| 1 package in 1 bag / 10 mL in 1 package | 0404-9855-99 | Henry Schein | 10 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 December 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Doxycycline 100 mg/10 mL powder for injection.
Other strengths and forms of Doxycycline
Clinical summary
Doxycycline is a tetracycline-class drug indicated for the treatment of infections, among other approved uses. It is available as capsules, tablets and powder for injection for oral and intravenous use. MedsAcross supplies Doxycycline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxycyclineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxycycline prescribing information (Wellhouse Pharma) · U.S. National Library of Medicine, DailyMed
Need Doxycycline 100 mg/10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.